BOBULSKY SUSAN 4
4 · Adaptive Biotechnologies Corp · Filed Oct 1, 2020
Insider Transaction Report
Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-09-29−10,000→ 55,000 totalExercise: $1.98Exp: 2024-10-13→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2020-09-29$1.98/sh+10,000$19,800→ 10,000 total - Sale
Common Stock
2020-09-29$50.00/sh−10,000$500,000→ 0 total
Footnotes (2)
- [F1]These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.
- [F2]All options are fully exercisable.